Lercanidipine

From WikiMD's WELLNESSPEDIA

Lercanidipine is a calcium channel blocker of the dihydropyridine class, specifically designed to treat hypertension. It is marketed under various trade names.

Etymology[edit]

The name "Lercanidipine" is derived from the chemical structure of the drug, which is a dihydropyridine calcium antagonist. The prefix "Ler-" is derived from the name of the company that first synthesized the drug, Recordati's Lercanidipine.

Pharmacology[edit]

Lercanidipine inhibits the influx of calcium ions through L-type calcium channels in the cell membrane, reducing the amount of calcium available for smooth muscle contraction. This results in vasodilation and a reduction in blood pressure.

Clinical Use[edit]

Lercanidipine is used primarily for the treatment of hypertension. It is typically administered once daily, with the dose adjusted according to the patient's response and tolerance. The drug is well tolerated, with the most common side effects being headache, dizziness, and flushing.

Contraindications[edit]

Lercanidipine is contraindicated in patients with known hypersensitivity to dihydropyridines, severe hepatic impairment, and in patients with unstable angina or within one month of a myocardial infarction.

Interactions[edit]

Lercanidipine may interact with other drugs, including beta blockers, digoxin, warfarin, and cimetidine. It is also known to interact with grapefruit juice, which can increase the concentration of the drug in the bloodstream and enhance its effects.

Related Terms[edit]

Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Lercanidipine[edit]

  • (R)-Lercanidipine Structural Formula
    (R)-Lercanidipine Structural Formula
  • (S)-Lercanidipine Structural Formula
    (S)-Lercanidipine Structural Formula

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Lercanidipine&oldid=6314601"